CTRI/2017/08/009343招募中4 期
Comparative evaluation of efficacy and safety profile of various iron preparations in anaemic chronic kidney disease patients.
Jawaharlal Nehru Medical College Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient of Chronic kidney disease, Stage 3-5, haemoglobin <= 9 g/dL
- •2.Patient on or not on dialysis.
- •3.Serum ferritin level below 100 ng/mL in dialysis naïve patients and below 200 ng/mL in dialysis dependent patients
- •4.Transferrin saturation (TSAT) below 20%.
- •5.Written informed consent
排除标准
- •1.Pregnancy
- •2.Lactating females
- •3.Acute infection
- •4.Haematological disorders like thalessemia, leukemia,haemophilia
- •5.Haemochromatosis
- •6.Critically ill patient
- •HIV/HBsAg/Anti-HCV and immunocompromised patient.
- •Severe Renal pathology such as malignancy
研究者
相似试验
已完成
4 期
To evaluate the efficacy and the safety profile of Rhubarb and alpha-Keto amino acid supplementation on patients of Chronic kidney disease.CTRI/2012/09/002947Department Of Pharmacology And Department Of Medicine100
招募中
4 期
To know the safety and efficacy of Antioxidants in Patients of chronic obstructive pulmonary disease.CTRI/2015/01/005432Jawaharlal Nehru Medical College and Hospital Aligarh Muslim University Aligarh150
进行中(未招募)
不适用
Dexmedetomedine intravenous sedation on patients with and without Beta blockersCTRI/2018/08/015387ETHRADHAMA SUPER SPECIALITY EYE HOSPITA
招募中
3 期
Comparative assessment of the efficacy and safety of add ontreatment with Sofosbuvir standard of care therapeutic regimenVelpatasvir” to standard of caretherapeutic regimen” in patients with COVID-19COVID-19.COVID-19 diseaseU07.1IRCT20130812014333N145Kermanshah University of Medical Sciences80
招募中
3 期
Comparative assessment of the efficacy and safety of addon treatment with Sofosbuvir-Daclatasvir”, Lithium”,and Trifluoprazine” to standard of care in three groups of patients with COVID-19IRCT20130812014333N147Kermanshah University of Medical Sciences80
